Brughera Marco Maria
Visual SEC Form 4 history across 1 companies, 3 transactions and 1 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
sale at FENNEC PHARMACEUTICALS INC. on Sep 15, 2026 valued at $159,958.
Review SEC filingNo open-market insider purchase is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #221947 | FENC | Brughera Marco Maria | DIR | exercise10b5-1 | 15.5k | $0 | M | 09/16 | 09/15 |
| #221946 | FENC | Brughera Marco Maria | DIR | sale10b5-1 | 15.5k | -$15.9M | S | 09/16 | 09/15 |
| #221945 | FENC | Brughera Marco Maria | DIR | exercise10b5-1 | 15.5k | $3.27M | M | 09/16 | 09/15 |
Brughera Marco Maria Insider Activity FAQ
SEC Form 4 context
Who is Brughera Marco Maria?
Brughera Marco Maria is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001589776.
Which companies has Brughera Marco Maria reported transactions for?
FENNEC PHARMACEUTICALS INC.
When was Brughera Marco Maria's latest insider buy?
No open-market insider purchase is available for this period.
When was Brughera Marco Maria's latest insider sale?
sale at FENNEC PHARMACEUTICALS INC. on Sep 15, 2026 valued at $159,958.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.